Takahashi, S., Sakamoto, Y., Denda, T., Takashima, A., Komatsu, Y., Nakamura, M., . . . Ishioka, C. (2021). Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer. Cancer science, 112(4), 1567-1578. https://doi.org/10.1111/cas.14841
Chicago Style (17th ed.) CitationTakahashi, Shin, et al. "Advanced Colorectal Cancer Subtypes (aCRCS) Help Select Oxaliplatin‐based or Irinotecan‐based Therapy for Colorectal Cancer." Cancer Science 112, no. 4 (2021): 1567-1578. https://doi.org/10.1111/cas.14841.
MLA (9th ed.) CitationTakahashi, Shin, et al. "Advanced Colorectal Cancer Subtypes (aCRCS) Help Select Oxaliplatin‐based or Irinotecan‐based Therapy for Colorectal Cancer." Cancer Science, vol. 112, no. 4, 2021, pp. 1567-1578, https://doi.org/10.1111/cas.14841.